Prosecution Insights
Last updated: October 02, 2026
Application No. 18/380,454

Positive Resist Material And Patterning Process

Non-Final OA §103§DP
Filed
Oct 16, 2023
Priority
Oct 17, 2022 — JP 2022165997
Examiner
EOFF, ANCA
Art Unit
Tech Center
Assignee
Shin-Etsu Chemical Co., Ltd.
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
1007 granted / 1258 resolved
+20.0% vs TC avg
Moderate +11% lift
Without
With
+10.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
45 currently pending
Career history
1296
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
50.7%
+10.7% vs TC avg
§102
18.7%
-21.3% vs TC avg
§112
20.3%
-19.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1258 resolved cases

Office Action

§103 §DP
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-15 are pending. The foreign priority application No. 2022-165997 filed on October 17, 2022 in Japan has been received and it is acknowledged. Drawings The drawings are objected to because a single drawing used to illustrate the claimed invention must not be numbered, and the abbreviation “FIG.” must not appear (see 37 CFR 1.84 (u) Numbering of views). Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Specification The following guidelines illustrate the preferred layout for the specification of a utility application. These guidelines are suggested for the applicant’s use. Arrangement of the Specification As provided in 37 CFR 1.77(b), the specification of a utility application should include the following sections in order. Each of the lettered items should appear in upper case, without underlining or bold type, as a section heading. If no text follows the section heading, the phrase “Not Applicable” should follow the section heading: (a) TITLE OF THE INVENTION. (b) CROSS-REFERENCE TO RELATED APPLICATIONS. (c) STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT. (d) THE NAMES OF THE PARTIES TO A JOINT RESEARCH AGREEMENT. (e) INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A READ-ONLY OPTICAL DISC, AS A TEXT FILE OR AN XML FILE VIA THE PATENT ELECTRONIC SYSTEM. (f) STATEMENT REGARDING PRIOR DISCLOSURES BY THE INVENTOR OR A JOINT INVENTOR. (g) BACKGROUND OF THE INVENTION. (1) Field of the Invention. (2) Description of Related Art including information disclosed under 37 CFR 1.97 and 1.98. (h) BRIEF SUMMARY OF THE INVENTION. (i) BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING(S). (j) DETAILED DESCRIPTION OF THE INVENTION. (k) CLAIM OR CLAIMS (commencing on a separate sheet). (l) ABSTRACT OF THE DISCLOSURE (commencing on a separate sheet). (m) SEQUENCE LISTING. (See MPEP § 2422.03 and 37 CFR 1.821 - 1.825). A “Sequence Listing” is required on paper if the application discloses a nucleotide or amino acid sequence as defined in 37 CFR 1.821(a) and if the required “Sequence Listing” is not submitted as an electronic document either on read-only optical disc or as a text file via the patent electronic system. The specification of the instant application should be amended to recite under the heading (b) CROSS-REFERENCE TO RELATED APPLICATIONS that the application claims priority benefit from the foreign priority application No. 2022-165997 filed on October 17, 2022 in Japan. The disclosure is objected to because of the following informalities: “FIG.1” in par.0039 should be amended to recite “The FIGURE”. Appropriate correction is required. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1 and 4-15 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1 and 4-14 of copending Application No. 18/380,475 (US 2024/0168379) in view of Fukushima et al. (US 2020/0223796). The copending Application No. 18/380,475 claims a positive resist material comprising a compound having two or more urethane groups and having two or more carboxy groups that are each substituted with an acid labile group and are bonded to the urethane groups via a linking group (claim 1). The copending Application No. 18/380,475 does not claim that the positive resist material comprises the compound in claim 1 of the instant application. Fukushima et al. teach an onium salt of formula (I) included in a resist composition wherein the base comprises acid labile groups (a positive resist composition) (abstract, par.0024, par.0034). The resist composition has high sensitivity, is reduced in acid diffusion, improved in many lithography performance factors including exposure latitude (EL), mask error factor (MEF), line width roughness (LWR) and thus is best suited for precise micropatterning (par.0026). Therefore, it would have been obvious to include the onium salt of formula (I) of Fukushima et al. in the positive resist material of the copending Application No. 18/380,475 in order to improve the sensitivity, exposure latitude (EL), mask error factor (MEF), line width roughness (LWR), and reduce the acid diffusion in the resist material. Fukushima et al. teach the onium salt of formula (I): PNG media_image1.png 142 400 media_image1.png Greyscale , wherein RAL is an acid labile group, La1 and La2 may be carbamate bonds, Q+ is an onium cation (par.0027), and the onium cation may be a sulfonium cation or an iodonium cation (par.0031). A carbamate bond is a urethane bond, as evidenced in par.0017 of Tang (US 2003/0152533). Such onium salt is a compound having two or more carbamate (urethane) groups, a sulfonium or iodonium salt of a sulfonic acid, a carboxy group substituted with an acid-labile group and bonded to a first carbamate (urethane) group, and the sulfonium or iodonium salt bonded to a second carbamate (urethane) group directly or via a linking group in claim 1. Therefore, the resist material in claim 1 of the copending Application No. 18/380,475 modified by Fukushima is equivalent to the positive resist material in claims 1 and 4 of the instant application. The copending Application No. 18/380,475 further claims that the positive resist material further comprises a base polymer (claim 4), same as in claim 5 of the instant application. The copending Application No. 18/380,475 further claims that the base polymer comprises: a repeating unit having an acid-labile group substituting a hydrogen atom of a carboxy group; and/or a repeating unit having an acid-labile group substituting a hydrogen atom of a phenolic hydroxy group (claim 5), same as in claim 6 of the instant application. The copending Application No. 18/380,475 further claims that the repeating unit having an acid-labile group substituting a hydrogen atom of a carboxy group and the repeating unit having an acid-labile group substituting a hydrogen atom of a phenolic hydroxy group are respectively a repeating unit represented by the following formula (a1) or (a2): PNG media_image2.png 260 380 media_image2.png Greyscale wherein each RA independently represents a hydrogen atom or a methyl group; X1 represents a single bond or a linking group having 1 to 14 carbon atoms and containing a phenylene group, a naphthylene group, an ester band, an ether bond, or a lactone ring; X2 represents a single bond, an ester bond, or an amide bond; X3 represents a single bond, an ether bond, or an ester bond, R11 and R12 represent acid labile groups, R13 represents a fluorine atom, a trifluoromethyl group, a cyano group, or a saturated hydrocarbyl group having 1 to 6 carbon atoms; R14 represents a single bond or a saturated hydrocarbylene group having 1 to 6 carbon atoms, part of the carbon atoms optionally being substituted with an ether bond or an ester bond; and "a" represents 1 or 2 and "b" represents an integer of 0 to 4, provided that a+b are between 1 and 5 (claim 6), same as in claim 7 of the instant application. The copending Application No. 18/380,475 further claims that the base polymer further comprises a repeating unit (b) having an adhesive group selected from a hydroxy group, a carboxy group, a lactone ring, a carbonate group, a thiocarbonate group, a carbonyl group, a cyclic acetal group, an ether bond, an ester bond, a sulfonic acid ester bond, a cyano group, an amide bond, -O-C(=O)-S-, and -O-C(=O)-NH- (claim 7), same as in claim 8 of the instant application. The copending Application No. 18/380,475 further claims that the base polymer further comprises a repeating unit (c) represented by one or more of the following formulae (c1) to (c3): PNG media_image3.png 210 564 media_image3.png Greyscale , wherein each RA independently represents a hydrogen atom or methyl group, Y1 represents a single bond, a phenylene group, a naphthylene group, -O-Y11-, -C(=O)-O-Y11-, or -C(=O)-NH-Y11-, Y11 represents an aliphatic hydrocarbylene group having 1 to 6 carbon atoms, a phenylene group, a naphthylene group, or a group having 7 to 18 carbon atoms derived from a combination of these groups, Y'1 optionally containing a carbonyl group, an ester bond, an ether bond, or a hydroxy group; Y2 represents a single bond or an ester bond; Y3 represents a single bond, -Y31-C (=O)-O-, -Y31-O-,or -Y31-O-C(=O) -; Y31 represents a hydrocarbylene group having 1 to 12 carbon atoms, a phenylene group, or a group having 7 to 18 carbon atoms derived from a combination of these groups, Y31 optionally containing a carbonyl group, an ester bond, an ether bond, an iodine atom, or a bromine atom; Y4 represents a single bond, a methylene group, or a 2,2,2-trifluoro-l,1-ethanediyl group; Y5 represents a single bond, a methylene group, an ethylene group, a phenylene group, a fluorinated phenylene group, -O-Y51-, -C(=O)-O-Y51-, or C(=O)-NH-Y51-, Y51 represents an aliphatic hydrocarbylene group having 1 to 6 carbon atoms, a phenylene group, or a group having 7 to 18 carbon atoms derived from a combination of these groups, Y51 optionally containing a carbonyl group, an ester bond, an ether bond, or a hydroxy group; Rf1 and Rf2 each independently represent a hydrogen atom, a fluorine atom, or a trifluoromethyl group, provided that at least one of Rf1 and Rf2 is a fluorine atom; R21 to R28 each independently represent a hydrocarbyl group having 1 to 20 carbon atoms and optionally containing a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, or a heteroatom; R23 and R24 or R26 and R27 are optionally bonded with each other to form a ring together with a sulfur atom bonded to R23 and R24or R26 and R27; and M- represents a non-nucleophilic counter ion (claim 8), same as in claim 9 of the instant application. The copending Application No. 18/380,475 further claims that the positive resist material further comprises an acid generator (claim 9), same as in claim 10 of the instant application. The copending Application No. 18/380,475 further claims that the positive resist material further comprises an organic solvent (claim 10), same as in claim 11 of the instant application. The copending Application No. 18/380,475 further claims that the positive resist material further comprises a quencher (claim 11), same as in claim 12 of the instant application. The copending Application No. 18/380,475 further claims that the positive resist material further comprises a surfactant (claim 12), same as in claim 13 of the instant application. The copending Application No. 18/380,475 further claims a patterning process comprising the steps of: forming a resist film on a substrate by using the positive resist material according, exposing the resist film to a high-energy beam, and developing the exposed resist film by using a developer (claim 13), same as in claim 14 of the instant application. The copending Application No. 18/380,475 further claims that the high-energy beam is an i-line beam, a KrF excimer laser beam, an ArF excimer laser beam, an electron beam, or an extreme ultraviolet ray having a wavelength of 3 to 15 nm (claim 14), same as in claim 15 of the instant application. This is a provisional nonstatutory double patenting rejection. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-3 and 5-15 are rejected under 35 U.S.C. 103 as being unpatentable over Fukushima et al. (US 2020/0223796). With regard to claim 1, Fukushima et al. teach the onium salt of formula (I): PNG media_image1.png 142 400 media_image1.png Greyscale , wherein RAL is an acid labile group, La1 and La2 may be carbamate bonds, Q+ is an onium cation (par.0027), and the onium cation may be a sulfonium cation or an iodonium cation (par.0031). Fukushima et al. do not specifically teach an onium salt of formula (I) wherein RAL is an acid labile group, La1 and La2 are carbamate bonds, and Q+ is sulfonium cation or an iodonium cation. However, it would have been obvious to one of ordinary skill in the art before the filing date of the claimed invention to obtain an onium salt of formula (I) wherein RAL is an acid labile group, La1 and La2 are carbamate bonds, and Q+ is sulfonium cation or an iodonium cation, because Fukushima et al. teach the onium salt of formula (I) and teach the groups RAL, La1, La2, and Q+. A carbamate bond is a urethane bond, as evidenced in par.0017 of Tang (US 2003/0152533). Such onium salt is a compound having two or more carbamate (urethane) groups, a sulfonium or iodonium salt of a sulfonic acid, a carboxy group substituted with an acid-labile group and bonded to a first carbamate (urethane) group, and the sulfonium or iodonium salt bonded to a second carbamate (urethane) group directly or via a linking group in claim 1. The onium salt is included in a resist composition wherein the base comprises acid labile groups (a positive resist composition) (abstract, par.0024, par.0034). With regard to claim 2, a carbamate (urethane) bond is represented by the formula -O-C(=O)-NH- or by the formula -NH-C(=O)-O-, as evidenced in par.0037 of Brooks (US 2011/0117660). The onium salt of formula (I) wherein Rf1 and Rf2 are each independently fluorine or C1-C6 fluoroalkyl group, Rf3 and Rf4 are each independently hydrogen, fluorine, or a C1-C6 fluoroalkyl group, RAL is an acid labile group, La1 is a carbamate(urethane) bond of formula -O-CO-NH-, La2 is a carbamate (urethane) bond of formula -NH-CO-O-, XL is a C2-C40 divalent hydrocarbon group, , k is an integer from 1 to 3, and Q+ is sulfonium cation or an iodonium cation of Fukushima et al. is a compound of formula (1) in claim 2, wherein p=1, r=1, q=1, R1 is an acid labile group, R2 is a linking group, R3 is a hydrocarbylene with 2-40 carbon atoms, R4 is a single bond or a linking group, Rf1 to Rf4 are fluorine atoms, and C1-C6 fluoroalkyl groups. A group R3 comprising 2-40 carbon atoms includes the range of 2 to 33 carbon atoms for R3 in claim 2. The ranges of C1-C6 fluoroalkyl groups for Rf1 to Rf4 includes the trifluoromethyl group in claim 2. With regard to claim 3, Fukushima et al. teach that the acid labile group RAL may be a tertiary ester (par.0096)., which meets the composition 1) in claim 3. With regard to claim 5, Fukushima et al. teach that the resist composition comprises a base resin (par.0034). With regard to claims 6 and 7, Fukushima et al. teach that the base resin comprises recurring units having the formula (a1) or (a2): PNG media_image4.png 182 440 media_image4.png Greyscale PNG media_image5.png 214 436 media_image5.png Greyscale , wherein RA is each hydrogen, fluorine, methyl or trifluoromethyl, ZA may be a single bond, phenylene, naphthylene, XA and XB are each independently an acid labile group, n=0-4, R21 is a C1-C20 monovalent hydrocarbon group which may comprise a heteroatom (par.0034. par.0124-0125). The repeating unit of formula (a1) of Fukushima et al. is a repeating unit having an acid labile group substituting a hydrogen from a carboxy group in claim 6, and a repeating unit of formula (a1) in claim 7 of the instant application. The repeating unit of formula (a2) of Fukushima et al. is a repeating unit having an acid labile group substituting a hydrogen from a phenolic hydroxy group in claim 6, and a repeating unit of formula (a2) in claim 7 of the instant application. With regard to claim 8, Fukushima et al. teach that the base resin may further comprises a repeating unit of formula (b1): PNG media_image6.png 156 424 media_image6.png Greyscale , wherein YA may be a polar group selected from hydroxyl, cyano, carboxyl, an ester bond, an ether bond, a sulfonic acid ester bond, a carbonate bond, a lactone ring (par.0156-0157). With regard to claim 9, Fukushima et al. teach that the base resin may further comprises a repeating unit selected from repeating units of formulas (c1) to (c3): PNG media_image7.png 148 436 media_image7.png Greyscale PNG media_image8.png 220 418 media_image8.png Greyscale PNG media_image9.png 132 460 media_image9.png Greyscale , wherein RA is each independently hydrogen, fluorine, methyl, or trifluoromethyl, Z1 is a single bond, phenylene or -O-Z11-, -C(=O)-O-Z11- or -C(=O)-NH-Z11-, Z11 is a C1-C20 alkanediyl group, C2-C20 alkenediyl group or phenylene group which may contain a carbonyl moiety, ester bond, ether bond, or hydroxyl moiety, Z2 is a single bond or -Z21-C(=O)-O-, Z21 is a C1-C20 divalent hydrocarbon group with may contain a heteroatom, Z3 is a single bond, methylene ethylene, phenylene, fluorinated phenylene, -O-Z31-, -C(=O)-O-Z31- or -C(=O)-NH-Z31-, Z31 is a C1-C6 alkanediyl group, C2-C8 alkenediyl group or phenylene group which may contain a carbonyl moiety, ester bond, ether bond, or hydroxyl moiety, R31 and R32 are each independently a C1-C20 monovalent hydrocarbon group which may contain a heteroatom, R31 and R32 may bond together to form a ring with the sulfur atom to which they are attached, M- is a non-nucleophilic counter ion, and A+ may be sulfonium cation (par.0035-0036). With regard to claims 10-13, Fukushima et al. teach that the resist composition further comprises a photoacid generator (par.0037-0042), an organic solvent (par.0187), an amine compound (par.0042) and a surfactant (par.0043). An amine acts as a quencher, as defined in par.0273 of the specification of the instant application. With regard to claims 14 and 15, Fukushima et al. teach a process comprising the steps of: -applying the resist composition onto a substrate and forming a resist film; -exposing the resist film; and -developing the resist film (par.0252). The exposure may be performed with ArF excimer laser, KrF excimer laser, electron beam (EB), or extreme ultraviolet (EUV)(par.0252). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANCA EOFF whose telephone number is (571)272-9810. The examiner can normally be reached Mon-Fri 10am-6:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niki Bakhtiari can be reached at (571)272-3433. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANCA EOFF/Primary Examiner, Art Unit 1722
Read full office action

Prosecution Timeline

Oct 16, 2023
Application Filed
Aug 13, 2026
Non-Final Rejection mailed — §103, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12736879
Bismaleimide Compound, Composition Containing Same, Polybenzoxazole, And Semiconductor Device
3y 7m to grant Granted Sep 15, 2026
Patent 12731864
LITHIUM BATTERY AND MANUFACTURING METHOD THEREFOR
3y 2m to grant Granted Sep 08, 2026
Patent 12731861
SEPARATOR FOR ELECTROCHEMICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME
3y 6m to grant Granted Sep 08, 2026
Patent 12731858
OXIDIZED BACTERIAL CELLULOSE SEPARATOR FOR BATTERIES AND METHOD FOR PRODUCING THE SAME
3y 8m to grant Granted Sep 08, 2026
Patent 12725829
CROSS-LINKED SOLID-POLYMER ELECTROLYTES, METHODS OF MAKING SAME, AND USES THEREOF
4y 0m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
91%
With Interview (+10.8%)
2y 8m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1258 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month